Sulzer proposes InCentive's Braginsky to board
This article was originally published in Clinica
Sulzer Medica is to nominate Rene Braginsky of InCentive Capital to its board of directors. The company is Sulzer Medica's largest shareholder and was responsible for last year's unsuccessful takeover bid for the Swiss company's former parent (see Clinica No 954, p 17). Via the attempt, Mr Braginsky did, however, succeed in his aim of getting Sulzer's medical arm spun off into a separate company, which happened in July 2001.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.